Harvey C. Krasny

933 total citations
23 papers, 767 citations indexed

About

Harvey C. Krasny is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Harvey C. Krasny has authored 23 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 8 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Harvey C. Krasny's work include Herpesvirus Infections and Treatments (14 papers), Cytomegalovirus and herpesvirus research (6 papers) and Toxin Mechanisms and Immunotoxins (5 papers). Harvey C. Krasny is often cited by papers focused on Herpesvirus Infections and Treatments (14 papers), Cytomegalovirus and herpesvirus research (6 papers) and Toxin Mechanisms and Immunotoxins (5 papers). Harvey C. Krasny collaborates with scholars based in United States and United Kingdom. Harvey C. Krasny's co-authors include P de Miranda, Gertrude B. Elion, Paul S. Lietman, Oscar L. Laskin, David J. Holbrook, Donald J. Nelson, Christopher J.L. Buggé, Steven S. Good, Andrew Whelton and James D. Connor and has published in prestigious journals such as The American Journal of Medicine, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Harvey C. Krasny

23 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harvey C. Krasny United States 16 424 211 160 109 90 23 767
Ann L. Silverman United States 19 612 1.4× 336 1.6× 135 0.8× 141 1.3× 47 0.5× 52 1.3k
Gerond Lake‐Bakaar United States 17 454 1.1× 96 0.5× 227 1.4× 93 0.9× 84 0.9× 52 1.1k
Chan‐Loi Yong United States 13 400 0.9× 162 0.8× 260 1.6× 88 0.8× 72 0.8× 22 944
F Miglio Italy 16 534 1.3× 178 0.8× 55 0.3× 113 1.0× 109 1.2× 63 1.2k
E. Musch Germany 14 130 0.3× 127 0.6× 85 0.5× 152 1.4× 113 1.3× 44 623
J. H. M. Van Tongeren Netherlands 22 273 0.6× 210 1.0× 35 0.2× 237 2.2× 83 0.9× 60 1.3k
A K Azad Khan United Kingdom 5 373 0.9× 73 0.3× 43 0.3× 125 1.1× 83 0.9× 10 949
Robert R. LaBadie United States 21 139 0.3× 234 1.1× 211 1.3× 191 1.8× 62 0.7× 51 1.0k
Keith Nieforth United States 16 249 0.6× 137 0.6× 214 1.3× 88 0.8× 103 1.1× 31 792
C. N. Williams Canada 20 846 2.0× 245 1.2× 55 0.3× 426 3.9× 208 2.3× 55 2.0k

Countries citing papers authored by Harvey C. Krasny

Since Specialization
Citations

This map shows the geographic impact of Harvey C. Krasny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harvey C. Krasny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harvey C. Krasny more than expected).

Fields of papers citing papers by Harvey C. Krasny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harvey C. Krasny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harvey C. Krasny. The network helps show where Harvey C. Krasny may publish in the future.

Co-authorship network of co-authors of Harvey C. Krasny

This figure shows the co-authorship network connecting the top 25 collaborators of Harvey C. Krasny. A scholar is included among the top collaborators of Harvey C. Krasny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harvey C. Krasny. Harvey C. Krasny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clair, M H St, John E. Reardon, Harvey C. Krasny, et al.. (1995). Antiviral, metabolic, and pharmacokinetic properties of the isomeric dideoxynucleoside 4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol. Antimicrobial Agents and Chemotherapy. 39(9). 1993–1999. 44 indexed citations
2.
Krasny, Harvey C. & Brent G. Petty. (1987). Metabolism of Desciclovir, a Prodrug of Acyclovir, in Humans After Multiple Oral Dosing. The Journal of Clinical Pharmacology. 27(1). 74–77. 9 indexed citations
3.
Petty, Brent G., R. J. Whitley, Sam Liao, et al.. (1987). Pharmacokinetics and tolerance of desciclovir, a prodrug of acyclovir, in healthy human volunteers. Antimicrobial Agents and Chemotherapy. 31(9). 1317–1322. 16 indexed citations
4.
Greffe, Brian, et al.. (1986). Transplacental passage of acyclovir. The Journal of Pediatrics. 108(6). 1020–1021. 25 indexed citations
5.
Krasny, Harvey C. & Thomas A. Krenitsky. (1986). Allopurinol as an inhibitor of the in vivo formation of acyclovir from desciclovir. Biochemical Pharmacology. 35(23). 4339–4340. 5 indexed citations
6.
Good, Steven S., Harvey C. Krasny, Gertrude B. Elion, & P de Miranda. (1983). Disposition in the dog and the rat of 2, 6-diamino-9-(2-hydroxyethoxymethyl)purine (A134U), a potential prodrug of acyclovir.. Journal of Pharmacology and Experimental Therapeutics. 227(3). 644–651. 20 indexed citations
7.
Laskin, Oscar L., James Longstreth, Andrew Whelton, et al.. (1982). Effect of renal failure on the pharmacokinetics of acyclovir. The American Journal of Medicine. 73(1). 197–201. 55 indexed citations
8.
Miranda, P de, et al.. (1982). Species differences in the disposition of acyclovir. The American Journal of Medicine. 73(1). 31–35. 51 indexed citations
9.
Miranda, P de, Steven S. Good, Harvey C. Krasny, et al.. (1982). Metabolic fate of radioactive acyclovir in humans. The American Journal of Medicine. 73(1). 215–220. 40 indexed citations
10.
Laskin, Oscar L., James Longstreth, Andrew Whelton, et al.. (1982). Acyclovir kinetics in end-stage renal disease. Clinical Pharmacology & Therapeutics. 31(5). 594–601. 38 indexed citations
11.
Krasny, Harvey C., Sam Liao, P de Miranda, et al.. (1982). Influence of hemodialysis on acyclovir pharmacokinetics in patients with chronic renal failure. The American Journal of Medicine. 73(1). 202–204. 34 indexed citations
12.
Miranda, P de, Steven S. Good, Oscar L. Laskin, et al.. (1981). Disposition of intravenous radioactive acyclovir. Clinical Pharmacology & Therapeutics. 30(5). 662–672. 70 indexed citations
13.
Miranda, P de, et al.. (1981). The disposition of acyclovir in different species.. Journal of Pharmacology and Experimental Therapeutics. 219(2). 309–315. 97 indexed citations
14.
Krasny, Harvey C., P de Miranda, Martin Blum, & Gertrude B. Elion. (1981). Pharmacokinetics and bioavailability of acyclovir in the dog.. Journal of Pharmacology and Experimental Therapeutics. 216(2). 281–288. 44 indexed citations
15.
Krasny, Harvey C. & David J. Holbrook. (1978). Effects of cadmium on heme oxygenase and hemoproteins in smooth and rough endoplasmic reticulum of rat liver. Biochemical Pharmacology. 27(3). 364–366. 20 indexed citations
16.
Krasny, Harvey C. & David J. Holbrook. (1977). Effects of Cadmium on Microsomal Hemoproteins and Heme Oxygenase in Rat Liver. Molecular Pharmacology. 13(4). 759–765. 52 indexed citations
17.
Nelson, Donald J., et al.. (1977). Oxypurine and 6-Thiopurine Nucleoside Triphosphate Formation in Human Erythrocytes. PubMed. 76A. 121–128. 8 indexed citations
18.
Nelson, Donald J., Christopher J.L. Buggé, Harvey C. Krasny, & Gertrude B. Elion. (1973). Formation of nucleotides of [6-14C]allopurinol and [6-14C]oxipurinol in rat tissues and effects on uridine nucleotide pools. Biochemical Pharmacology. 22(16). 2003–2022. 70 indexed citations
19.
Nelson, Donald J., Christopher J.L. Buggé, Harvey C. Krasny, & Thomas P. Zimmerman. (1973). Separation of 6-thiopurine derivatives on deae-sephadex columns and in the high-pressure liquid chromatograph. Journal of Chromatography A. 77(1). 181–190. 36 indexed citations
20.
Biddle, Fred G. & Harvey C. Krasny. (1970). The association of carbonic anhydrase activity with the non-hemo- globin erythrocytic protein (pro-1) of the house mouse. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 374. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ann L. Silverman Breakdown of academic impact, for papers by Gerond Lake‐Bakaar Breakdown of academic impact, for papers by Chan‐Loi Yong Breakdown of academic impact, for papers by F Miglio Breakdown of academic impact, for papers by E. Musch Breakdown of academic impact, for papers by J. H. M. Van Tongeren Breakdown of academic impact, for papers by A K Azad Khan Breakdown of academic impact, for papers by Robert R. LaBadie Breakdown of academic impact, for papers by Keith Nieforth Breakdown of academic impact, for papers by C. N. Williams
Rankless by CCL
2026